Survey: Clinical Research Priorities for UK Cardio-Oncology

Dear members,

The NIHR-BHF Cardiovascular Partnership theme in Cardio-Oncology is a new project bringing cardiology and oncology specialists together with patient representatives. Its aims are to inform cardio-oncology research priorities, to facilitate research study design and to maximise collaboration across the UK.

On behalf of Professor Ninian Lang, the Lead for the NIHR-BHF Cardiovascular Partnership theme in Cardio-Oncology, we would like to share a survey that has been developed to ensure the voices of all key stakeholders are heard for this important national initiative.

The link to the survey can be found here: Clinical Research Priorities for UK Cardio-Oncology: NIHR-BHF Partnership Survey

Do you have a specialist interest in cardio-oncology and would like to help inform the future research priorities in this area? The NIHR-BHF Cardiovascular Partnership theme in Cardio-Oncology is keen to hear from you to help facilitate future research study design and to maximised collaboration across the UK. Please take 10 minutes to complete the survey above, which seeks to gain an overview of opinions from UK-based healthcare professionals in relation to cardio-oncology research priorities. This will inform future discussions and funding applications for collaborative UK cardio-oncology research. For further information, please contact enquiries@bhfcrc.org.

Many thanks for taking part in this survey and making sure your voice is heard in cardio-oncology research in the UK.

Kind regards,

BOPA research subcommittee

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article